Modern medicine has come a long way in helping us prevent illness or the spread of diseases. But the question of are these drugs being tested enough to keep us safe?
Levaquin is one such drug that we will look into. Levaquin is a synthetic drug agent that is primarily used to treat severe bacterial infections. It is in the fluoroquinolone class of antiinfectives.
Levaquin is manufactured by the US Company Ortho-McNeil-Janssen Pharmaceuticals, Inc. The FDA approved this drug back in 1996 for use in the US for fighting massive bacterial infections. This drug reportedly has made Ortho-McNeil-Janssen over 1.6 billion in sales.
Presently there is concern in the medical community related to sever side effects from the use of Levaquin and other fluoroquinolone antibiotics. This drug can be administered in various ways – the most common being in tablet forms. Other methods also include an oral solution and an injection type of administration.
Many in the medical community believe that quinolones may be toxic to human tissue.
Anaphylactic reactions and allergic skin reactions, serious, occasionally fatal, may occur after first dose. Severe, and sometimes fatal, hepatoxicity has been reported. Central nervous system effects, including convulsions, anxiety, confusion, depression, and insomnia may occur after the first dose.
The FDA Issues Warning on Levaquin Labels.
When the FDA took note of the side effects being seen in the population, it issued a label change for the drug to fully illustrate the warnings associated with taking quinolones including Levaquin.
The following is the actual warning from the FDA:
Fluoroquinolones, including LEVAQUIN®, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants [See Warnings and Precautions (5.1)].
Source: accessdata.fda.gov
We have noted that the legal community is preparing strong actions against Ortho-McNeil-Janssen Pharmaceuticals, as websites for victims of these injuries have started to appear. Many are seeking compensation from the know side effects, especially the tendon rupture type cases.
Levaquin is one such drug that we will look into. Levaquin is a synthetic drug agent that is primarily used to treat severe bacterial infections. It is in the fluoroquinolone class of antiinfectives.
Levaquin is manufactured by the US Company Ortho-McNeil-Janssen Pharmaceuticals, Inc. The FDA approved this drug back in 1996 for use in the US for fighting massive bacterial infections. This drug reportedly has made Ortho-McNeil-Janssen over 1.6 billion in sales.
Presently there is concern in the medical community related to sever side effects from the use of Levaquin and other fluoroquinolone antibiotics. This drug can be administered in various ways – the most common being in tablet forms. Other methods also include an oral solution and an injection type of administration.
- The dangers of these types of fluoroquinolone products including Levaquin have been profound. While the vast majority of injures include tendon damage or tendon ruptures, there are also reports of nerves injuries, joint pains, and cardiac effects.
Many in the medical community believe that quinolones may be toxic to human tissue.
Anaphylactic reactions and allergic skin reactions, serious, occasionally fatal, may occur after first dose. Severe, and sometimes fatal, hepatoxicity has been reported. Central nervous system effects, including convulsions, anxiety, confusion, depression, and insomnia may occur after the first dose.
The FDA Issues Warning on Levaquin Labels.
When the FDA took note of the side effects being seen in the population, it issued a label change for the drug to fully illustrate the warnings associated with taking quinolones including Levaquin.
The following is the actual warning from the FDA:
Fluoroquinolones, including LEVAQUIN®, are associated with an increased risk of tendinitis and tendon rupture in all ages. This risk is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart or lung transplants [See Warnings and Precautions (5.1)].
Source: accessdata.fda.gov
We have noted that the legal community is preparing strong actions against Ortho-McNeil-Janssen Pharmaceuticals, as websites for victims of these injuries have started to appear. Many are seeking compensation from the know side effects, especially the tendon rupture type cases.